Adiponectin and cardiac geometry and function in elderly: Results from two community-based cohort studies

European Journal of Endocrinology

Volumn 162, Issue 3, 2010, Pages 543-550

  Gustafsson, Stefan ^a   Lind, Lars ^b   Zethelius, Björn ^c   Venge, Per ^b   Flyvbjerg, Allan ^d   Söderberg, Stefan ^e   Ingelsson, Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMMUNITY TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GERIATRICS; GLUCOSE BLOOD LEVEL; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION TESTS; HUMANS; LIPIDS; LONGITUDINAL STUDIES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; SEX FACTORS; STROKE VOLUME; WAIST CIRCUMFERENCE;

EID: 77149146162     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1006     Document Type: Article

References (41)

1. Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Education for Health 2003 16 230.
2. Prevention of Cardiovascular Disease: Guideline for Assessment and Management of Cardiovascular Risk. Geneva: World Health Organization, 2007.
3. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nature Clinical Practice. Cardiovascular Medicine 2006 3 35-42.
4. Nishida M, Funahashi T & Shimomura I. Pathophysiological significance of adiponectin. Medical Molecular Morphology 2007 40 55-67.
5. Ebinc H, Ebinc FA, Ozkurt ZN, Dogru MT, Tulmac M, Yilmaz M & Caglayan O. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocrine Journal 2008 55 523-528.
6. Ybarra J, Pou JM, Planas F, Ballesta-Lopez C, Echevarne F, Romeo JH & Navarro-Lopez F. Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study. Endocrine Practice 2007 13 590-600.
7. Hong SJ, Park CG, Seo HS, Oh DJ & Ro YM. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Pressure 2004 13 236-242.
8. Top C, Sahan B & Onde ME. The relationship between left ventricular mass index and insulin sensitivity, postprandial glycaemia, and fasting serum triglyceride and adiponection levels in patients with type 2 diabetes. Journal of International Medical Research 2007 35 909-916.
9. Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, Palombo C & Ferrannini E. Adiponectin and left ventricular structure and function in healthy adults. Journal of Clinical Endocrinology and Metabolism 2008 93 2811-2818.
10. Mitsuhashi H, Yatsuya H, Tamakoshi K, Matsushita K, Otsuka R, Wada K, Sugiura K, Takefuji S, Hotta Y, Kondo T, Murohara T & Toyoshima H. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 2007 49 1448-1454.
11. Ohara T, Kim J, Asakura M, Asanuma H, Nakatani S, Hashimura K, Kanzaki H, Funahashi T, Tomoike H & Kitakaze M. Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects. Hypertension Research 2008 31 825-831.
12. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A & Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005 112 1756-1762.
13. Haugen E, Furukawa Y, Isic A & Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. International Journal of Cardiology 2008 125 216-219.
14. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T & Kimura T. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circulation Journal 2007 71 623-630.
15. Lind L, Fors N, Hall J, Marttala K & Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 2368-2375.
16. Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Upsala Journal of Medical Sciences. Supplement 1975 19 1-61.
17. Sundström J, Ärnlöv J, Stolare K & Lind L. Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study. Heart 2008 94 874-878.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I & Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology 1986 57 450-458.
19. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O & Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. Journal of the American College of Cardiology 1992 20 1251-1260.
20. Teichholz LE, Kreulen T, Herman MV & Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. American Journal of Cardiology 1976 37 7-11.
21. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I & Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. Journal of the American College of Cardiology 1992 19 1550-1558.
22. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A & Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. Journal of Clinical Endocrinology and Metabolism 2007 92 571-576.
23. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, Grossman E, Sheps D, Keren G & Roth A. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006 92 1420-1424.
24. Ingelsson E, Riserus U, Berne C, Frystyk J, Flyvbjerg A, Axelsson T, Lundmark P & Zethelius B. Adiponectin and risk of congestive heart failure. Journal of the American Medical Association 2006 295 1772-1774.
25. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ & Meigs JB. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. Journal of the American College of Cardiology 2009 53 754-762.
26. Soderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, Simes J, Tonkin AM & Nestel P. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. International Journal of Obesity 2009 33 123-130.
27. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK & Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. Journal of the American College of Cardiology 1999 33 1948-1955.
28. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD & Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 459-469.
29. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K & Saruta T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science 2002 103 137-142.
30. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T & Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741.
31. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM & Bremner WJ. Testosterone administration suppresses adiponectin levels in men. Journal of Andrology 2005 26 85-92.
32. Sengenes C, Berlan M, De Glisezinski I, Lafontan M & Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB Journal 2000 14 1345-1351.
33. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M & Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. Journal of Biological Chemistry 2003 278 48617-48626.
34. Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M & Berlan M. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB Journal 2004 18 908-910.
35. Lavoie F, Frisch F, Brassard P, Normand-Lauziere F, Cyr D, Gagnon R, Drouin R, Baillargeon JP & Carpentier AC. Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. Journal of Clinical Endocrinology and Metabolism 2009 94 998-1004.
36. Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T & Horie M. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. European Journal of Heart Failure 2008 10 360-366.
37. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, AsaiM,Nagamachi Y, Maeda N, Shintani Y,Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H & Kitakaze M. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. Journal of the American College of Cardiology 2009 53 2070-2077.
38. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R & Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 1357-1362.
39. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA & Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004 279 12152-12162.
40. Shand B, Elder P, Scott R, Frampton C & Willis J. Biovariability of plasma adiponectin. Clinical Chemistry and Laboratory Medicine 2006 44 1264-1268.
41. Zethelius B, Byberg L, Hales CN, Lithell H & Berne C. Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 2002 105 2153-2158.